PT Darya-Varia Laboratoria Tbk (JKSE:DVLA) signed a deed of sale and purchase to acquire the remaining stake in PT Pradja Pharin from Marlia Hayati Goestam for IDR 0.02 million on April 17, 2014. Darya-Varia will acquire 1 share of PT Pradja Pharin for IDR 16,000. PT Pradja Pharin's assets totaled IDR 215.79 billion and booked net profit of IDR 34.83 billion in 2013 on sales of IDR 217.93 billion. The transaction is expected to close by June 30, 2014. The transaction requires approval from Darya-Varia and Pradja Pharin shareholders and approval from the Investment Coordination Board of Indonesia. It also required effective statement of merger from Financial Services Authority. Darya-Varia Laboratoria's shareholder meeting is scheduled for June 3, 2014. The extraordinary meeting of shareholders that was initially planned to be held on June 3, 2014 was suspended and had been completed on June 13, 2013. The transaction was approved by shareholders of PT Darya-Varia Laboratoria on June 13, 2014. Kantor Hukum Assegaf Hamzah acted as legal advisor for Pradja Pharin and Darya-Varia Laboratoria. KJPP Stefanus Tonny Hardi & Rekan acted as independent valuator, Kumala Tjahjani Widodo S.H. acted as notary in the transaction. Purwantono, Suherman & Surja acted as accountant for Darya-Varia Laboratoria and Pradja Pharin. Sharestar Indonesia acted as transfer agent for Darya-Varia.

PT Darya-Varia Laboratoria Tbk (JKSE:DVLA) completed the acquisition of the remaining stake in PT Pradja Pharin from Marlia Hayati Goestam on July 7, 2014.